RiverVest Venture Fund III, L.P.

13D and 13G Filings

13D/G filings
13D on 2 securities
Location
St. Louis, MO
CIK
0001601559
Form D filings
3 filings
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13D · 2 securities · may seek to influence control
OnKure Therapeutics, Inc. 13D/A
RPHM · 75974E103
1.6% 1/21/2025
Event 1/16/2025
Spruce Biosciences, Inc. 13D/A
SPRB · 85209E109
4.2% 1/10/2025
Event 1/7/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.